Technion Research and Development Foundation

Tomer Shlomi, PhD

August 17, 2019

Tomer Shlomi, PhDTechnion Institute (Israel) Targeting ovarian cancer via MTAP synthetic lethality Ovarian cancer cells are genetically unstable. A deletion of the gene MTAP, which is involved in methionine metabolism, is found in 3-15% of ovarian tumors. As a result, affected ovarian cancer cells have lost a functional enzyme for metabolizing old proteins which is […]

Read More